PULMONARY HYPERTENSION, INTERSTITIAL LUNG DISEASE
Clinical trials for PULMONARY HYPERTENSION, INTERSTITIAL LUNG DISEASE explained in plain language.
Never miss a new study
Get alerted when new PULMONARY HYPERTENSION, INTERSTITIAL LUNG DISEASE trials appear
Sign up with your email to follow new studies for PULMONARY HYPERTENSION, INTERSTITIAL LUNG DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill hopes to ease breathing in rare lung conditions
Disease control Recruiting nowThis study tests an experimental oral drug called ROC-101 in 40 adults with pulmonary arterial hypertension (PAH) or pulmonary hypertension linked to interstitial lung disease (ILD-PH). Participants take the drug alongside their standard care for 24 weeks, with a long-term follow…
Matched conditions: PULMONARY HYPERTENSION, INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: AllRock Bio, Inc. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Lifeline for lung patients: TPIP access extended
Disease control AVAILABLEThis study offers continued access to the inhaled drug TPIP for people with pulmonary arterial hypertension (PAH) or pulmonary hypertension linked to interstitial lung disease (PH-ILD) who have already completed a related study. Participants must have successfully finished prior …
Matched conditions: PULMONARY HYPERTENSION, INTERSTITIAL LUNG DISEASE
Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC